Ladenburg Thalmann Financial Services’s Clearside Biomedical CLSD Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$7K	Hold	160	–	–	﹤0.01%	4628
2019 Q3	$2K	Hold	160	–	–	﹤0.01%	4941
2019 Q2	$2K	Hold	160	–	–	﹤0.01%	4945
2019 Q1	$3K	Hold	160	–	–	﹤0.01%	4807
2018 Q4	$3K	Hold	160	–	–	﹤0.01%	4747
2018 Q3	$15K	Hold	160	–	–	﹤0.01%	4062
2018 Q2	$26K	Hold	160	–	–	﹤0.01%	3667
2018 Q1	$26K	Buy	160 +27	+20%	+$3.29K	﹤0.01%	3667
2017 Q4	$14K	Buy	+133	New	+$14.3K	﹤0.01%	3991

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CLSD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Clearside Biomedical (CLSD) position steady in Q4 2019 at 160 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Ladenburg Thalmann Financial Services first reported a position in CLSD in Q4 2017 and has held it in 9 quarters since. The position peaked at $26K in Q2 2018. 47 funds tracked by Wall St. Rank hold CLSD as of Q4 2019.

Ladenburg Thalmann Financial Services held 160 shares of Clearside Biomedical worth $7K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Clearside Biomedical share count unchanged in Q4 2019.
Clearside Biomedical made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4628 holding.
Ladenburg Thalmann Financial Services first reported a position in Clearside Biomedical in Q4 2017 and has held it in 9 quarters since.
Ladenburg Thalmann Financial Services's Clearside Biomedical position peaked at $26K in Q2 2018.
47 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.